| SASDX26 |
SARS-CoV-2 Nucleocapsid protein 3 mg/mL |
P0DTC9 | Single concentration |
1 | 0 | Published |
| SASDX27 |
Rv2514c VapC52 |
— | SEC-SAS |
1 | 1 | Published |
| SASDX28 |
SmThrRS model for closed state based on PDB entry 1qf6 |
B2FN79 | Single concentration |
1 | 2 | Published |
| SASDX29 |
Non Structural Protein 15 and ADPRP Macrodomain D |
P0DTD1 | Single concentration |
1 | 0 | Published |
| SASDX32 |
chloroplast trigger factor from Arabidopsis thaliana |
Q8S9L5 | Merged |
1 | 1 | Published |
| SASDX36 |
SARS-CoV-2 Nucleocapsid protein 4 mg/mL |
P0DTC9 | Single concentration |
1 | 0 | Published |
| SASDX37 |
Rv2514c-Rv2515c VapBC52 complex |
— | Single concentration |
1 | 1 | Published |
| SASDX38 |
SmThrRS model for closed state based on PDB entry 1nyr |
B2FN79 | Single concentration |
1 | 2 | Published |
| SASDX39 |
Group IIC Intron Domain 1 |
— | SEC-SAS |
1 | 1 | Published |
| SASDX42 |
IgA peptidase (A31-I1166; active site mutant E540A) |
Q9AES2 | Single concentration |
1 | 1 | Published |
| SASDX45 |
IgA protease (ThomasA) 31-1167 |
Q9AES2 | SEC-SAS |
1 | 0 | Published |
| SASDX46 |
Phosphorylated SARS-CoV-2 Nucleocapsid protein 0.5 mg/mL |
P0DTC9 | Single concentration |
1 | 0 | Published |
| SASDX48 |
SmThrRS model based on PDB entries 6vu9 and 1qf6 |
B2FN79 | Single concentration |
1 | 2 | Published |
| SASDX49 |
Group IIC intron Domain 1, 2 & 3 |
— | SEC-SAS |
1 | 1 | Published |
| SASDX52 |
Fatty acyl-CoA synthetase FadD5 |
O07411 | Single concentration |
1 | 1 | Published |
| SASDX54 |
Precursor microRNA 20a (pre-miR-20a) |
— | Co-flow SEC-SAS |
1 | 2 | Published |
| SASDX55 |
IgA protease (ThomasA) 31-878 |
Q9AES2 | SEC-SAS |
1 | 0 | Published |
| SASDX56 |
Phosphorylated SARS-CoV-2 Nucleocapsid protein 1 mg/mL |
P0DTC9 | Single concentration |
1 | 0 | Published |
| SASDX59 |
Group IIC intron Domain 1 & 2 |
— | SEC-SAS |
1 | 1 | Published |
| SASDX62 |
Fatty acyl-CoA synthetase FadD5 with 2 mM ATP |
O07411 | Single concentration |
1 | 1 | Published |
| SASDX64 |
Carboxylic ester hydrolase FphE |
Q2FDS6 | Co-flow SEC-SAS |
1 | 3 | Published |
| SASDX65 |
IgA protease (ThomasA) 323-878 |
Q9AES2 | SEC-SAS |
1 | 0 | Published |
| SASDX66 |
Phosphorylated SARS-CoV-2 Nucleocapsid protein 1.5 mg/mL |
P0DTC9 | Single concentration |
1 | 0 | Published |
| SASDX67 |
Non Structural Protein 15 in complex with RNA 9mer |
P0DTD1 | Single concentration |
1 | 0 | Published |
| SASDX69 |
Group IIC intron Domain 1, 2. 3 & 4 |
— | SEC-SAS |
1 | 1 | Published |
| SASDX72 |
Fatty acyl-CoA synthetase FadD5 with 2 mM coenzyme A (CoA) |
O07411 | Single concentration |
1 | 1 | Published |
| SASDX74 |
Carboxylic ester hydrolase FphF |
A0A0H2XFN6 | SEC-SAS |
1 | 3 | Published |
| SASDX75 |
Virulence factor family protein (VirJD1) from Brucella abortus |
A0AAE9RTQ7 | SEC-SAS |
1 | 0 | Published |
| SASDX76 |
Phosphorylated SARS-CoV-2 Nucleocapsid protein 2 mg/mL |
P0DTC9 | Single concentration |
1 | 0 | Published |
| SASDX77 |
Palladin Ig3-Ig4 tandem domain with linker swapped for the shorter Ig4-Ig5 Linnker |
Q9ET54 | Merged |
1 | 1 | Published |
| SASDX82 |
N-terminal domain of relaxase from Bacillus subtilis conjugative plasmid pLS20 |
E9RJ23 | Single concentration |
1 | 1 | Published |
| SASDX83 |
T. brucei Canonical Nucleosome Core Particle |
Q57YA3,Q389T1,Q4GYX7,Q57Z31 | SEC-SAS |
1 | 0 | Published |
| SASDX84 |
Peroxisomal targeting signal receptor Pex5 from P. pastoris |
P33292 | SEC-SAS |
1 | 1 | Published |
| SASDX86 |
Phosphorylated SARS-CoV-2 Nucleocapsid protein 3 mg/mL |
P0DTC9 | Single concentration |
1 | 0 | Published |
| SASDX87 |
human Citrate Synthase |
O75390 | SEC-SAS |
1 | 1 | Published |
| SASDX92 |
N-terminal domain of relaxase from Bacillus subtilis conjugative plasmid pLS20 in complex with the core region |
E9RJ23 | Single concentration |
1 | 2 | Published |
| SASDX93 |
T. brucei H3.V+H4.V Nucleosome Core Particle |
Q57YA3,Q389T1,Q387X7,Q587H6 | SEC-SAS |
1 | 0 | Published |
| SASDX94 |
Peroxisomal biogenesis factor 8 (Pex8) from P. pastoris |
Q01962 | SEC-SAS |
1 | 1 | Published |
| SASDX95 |
DNA repair protein RAD51 homolog 1 (RAD51) [F86E, A89E] in complex with Breast cancer type 2 susceptibility protein (BRCA2) truncation containing the second, third and fourth BRC repeats (BRC2-4) at 1 mg/mL |
P51587,Q06609 | Single concentration |
1 | 0 | Published |
| SASDX96 |
Phosphorylated SARS-CoV-2 Nucleocapsid protein 4 mg/mL |
P0DTC9 | Single concentration |
1 | 0 | Published |
| SASDX97 |
human Citrate Synthase |
O75390 | Single concentration |
1 | 1 | Published |
| SASDXA3 |
T. brucei H3.V-only Nucleosome Core Particle |
Q57YA3,Q389T1,Q57Z31,Q387X7 | SEC-SAS |
1 | 0 | Published |
| SASDXA4 |
Peroxisomal biogenesis factor 8 (Pex8) bound to Peroxisomal targeting signal receptor, Pex5 from P. pastoris |
P33292,Q01962 | SEC-SAS |
1 | 1 | Published |
| SASDXA5 |
DNA repair protein RAD51 homolog 1 (RAD51) [F86E, A89E] in complex with Breast cancer type 2 susceptibility protein (BRCA2) truncation containing the second, third and fourth BRC repeats (BRC2-4) at 2 mg/mL |
P51587,Q06609 | Single concentration |
1 | 0 | Published |
| SASDXA6 |
Non Structural Protein 9 (ORF1ab polyprotein) from SARS CoV-2 |
A0A679G4D8 | Single concentration |
1 | 0 | Published |
| SASDXA7 |
hexamer of human citrate synthase and human malate dehydrogenase 2 |
O75390,P40926 | SEC-SAS |
1 | 1 | Published |
| SASDXA9 |
Trypanosoma brucei gambiense, Variant Surface Glycoprotein (VSG) LiTat 1.3 |
X5GEX5 | SEC-SAS |
1 | 1 | Published |
| SASDXB2 |
Phosphoglycerate kinase |
A0A0W0EGC5 | SEC-SAS |
1 | 2 | Published |
| SASDXB3 |
Apical stem loop of stem loop 2 motif in Delta variant of SARS-CoV-2 (s2m Delta_short) |
— | Single concentration |
1 | 0 | Published |
| SASDXB4 |
Peroxisomal biogenesis factor 8 (Pex8) bound to the N-terminal domain of Peroxisomal targeting signal receptor, Pex5 (Pex8-Pex5NTD complex from P. pastoris) |
Q01962,P33292 | SEC-SAS |
1 | 1 | Published |